生物
细胞分化
癌症研究
免疫学
基因敲除
STAT1
外体
纤维化
炎症
T细胞
过敏性肺炎
细胞生物学
特发性肺纤维化
细胞
肺纤维化
白细胞介素17
下调和上调
T细胞受体
巨噬细胞
分子生物学
微泡
趋化因子受体
白细胞介素2受体
作者
Dan Peng,Juan Li,Bomiao Qin,Anying Xiong,Ran Qin,Lingling Bai,Xiang He,Xiaolan Li,Lei Zhang,Madeeha Arooj,Guoping Li
摘要
Th17 cells contribute to pulmonary fibrosis, but the mechanisms driving their differentiation remain unclear. Using single-cell RNA sequencing (scRNA-seq) and a decision tree model, we identify IL17A as a key marker in mice exposed to Saccharopolyspora rectivirgula antigen (SR-Ag). Trajectory and T cell receptor (TCR) analyses reveal IL17A⁺ CD4 T cells as terminally differentiated and clonally expanded. Blocking IL17A reduces SR-Ag-induced lung inflammation and fibrosis. Exosomal miR-6990-5p from MMP14-overexpressing macrophages promotes Th17 differentiation and fibroblast-to-myofibroblast transition (FMT) in vitro. It directly targets STAT1, as confirmed by luciferase assays. Co-immunoprecipitation (Co-IP) and docking analyses show STAT1 interacts with ROR-γt and RUNX1. STAT1 knockdown upregulates ROR-γt, IL17A, and RUNX1 in co-cultures with naïve CD4 T cells. In vivo, miR-6990-5p exacerbates fibrotic hypersensitivity pneumonitis (FHP) in SR-Ag-exposed mice. These findings indicate that miR-6990-5p induces Th17 cell differentiation through the STAT1/RUNX1/ROR-γt/IL17A pathway, contributing to FMT and fibrosis progression. This highlights miR-6990-5p as a potential therapeutic target for FHP.
科研通智能强力驱动
Strongly Powered by AbleSci AI